Endovascular lithotripsy and CO2 angiography could be valuable tools in the treatment of patients with PAD and chronic kidney disease

Chronic kidney disease (CKD) limits the outcomes of endovascular therapy in patients with PAD, while the use of contrast agent can lead to a further deterioration of the renal function. CO2 angiography and endovascular lithotripsy were used in this case in order to limit the need for nephrotoxic contrast agent in a patient with CLI and CKD.